Fernanda Novais
Overview
Explore the profile of Fernanda Novais including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
42
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jin J, Zhang R, Li J, Gao F, Liao Z, Yu Y, et al.
Proc Natl Acad Sci U S A
. 2025 Mar;
122(10):e2424061122.
PMID: 40030035
Optimal activation of CD8+ T cells is crucial for immunity-mediated destruction of cancer, requiring a substantial amount of proteins involved in metabolism, proliferation, and effector function. Despite extensive studies emphasizing...
2.
Amorim Sacramento L, Farias Amorim C, G Lombana C, Beiting D, Novais F, Carvalho L, et al.
PLoS Pathog
. 2024 May;
20(5):e1012211.
PMID: 38709823
Cytolytic CD8+ T cells mediate immunopathology in cutaneous leishmaniasis without controlling parasites. Here, we identify factors involved in CD8+ T cell migration to the lesion that could be targeted to...
3.
Amorim Sacramento L, Farias Amorim C, G Lombana C, Beiting D, Novais F, Carvalho L, et al.
bioRxiv
. 2023 Oct;
PMID: 37873253
Cytolytic CD8 T cells mediate immunopathology in cutaneous leishmaniasis without controlling parasites. Here, we identify factors involved in CD8 T cell migration to the lesion that could be targeted to...
4.
Davis R, Sharma S, Conceicao J, Carneiro P, Novais F, Scott P, et al.
J Leukoc Biol
. 2017 Jan;
101(3):739-749.
PMID: 28076241
The protozoan causes cutaneous leishmaniasis (CL) in endemic regions. In murine models, neutrophils (PMNs) are recruited to the site of infection soon after parasite inoculation. However, the roles of neutrophils...
5.
Khouri R, Novais F, Santana G, de Oliveira C, dos Santos M, Barral A, et al.
PLoS One
. 2011 Jan;
5(12):e14394.
PMID: 21200432
Background: Chemotherapy remains the primary tool for treatment and control of human leishmaniasis. However, currently available drugs present serious problems regarding side-effects, variable efficacy, and cost. Affordable and less toxic...